Corticosteroids are therapeutic agents widely used in the pharmacological treatment of skin diseases such as eczema or psoriasis. Unfortunately, their use is restricted by the side effects that frequently occur at the systemic level. The goal of the research described here was to develop and charact
In vitro percutaneous permeation of betamethasone and betamethasone 17-valerate
โ Scribed by Kiyoshi Kubota; Howard I. Maibach
- Book ID
- 102918914
- Publisher
- John Wiley and Sons
- Year
- 1993
- Tongue
- English
- Weight
- 854 KB
- Volume
- 82
- Category
- Article
- ISSN
- 0022-3549
No coin nor oath required. For personal study only.
โฆ Synopsis
Models of drug delivery devices that employ erodible permeable coatings must take care to avoid the unacceptably high rate of release that arises as the erodible coating disappears and the barrier to drug release vanishes. One solution to this safety problem has been to exhaust the drug reservoir just before this condition occurs. This design has the disadvantage of placing demands of high accuracy on the quality control in the fabrication of the device. A drug delivery system of cylindrical symmetry is proposed that uses two permeable coatings on a drug-containing core. Only the outer of the two coatings is erodible; the inner safety coating and the core are inert. Calculations are performed to design the device that can yield constant drug delivery rates while avoiding the possibility of explosive late drug release.
๐ SIMILAR VOLUMES
The role of viable skin layers (viable epidermis and dermis) is examined by the three-layer model using parameter values for betamethasone 17-valerate. The mathematical three-layer diffusion model indicates that the lag time and half-life after vehicle removal in epidermis and split-thickness skin a